The Journal of dermatological treatmentHumansDermatitisAtopicMaleAdult
Baricitinib for adult atopic dermatitis: real-world effectiveness, safety, and response predictors.
Niccolò Gori, Lucia Di Nardo, Elena Ippoliti, Flaminia Antonelli, Luisa Boeti, Anna Balato, Eugenia Veronica Di Brizzi, Maddalena Nicoletti, Maria Esposito, Maria Concetta Fargnoli, Andrea De Berardinis, Lina Maria Magnanimi, Marco Galluzzo, Claudia Paganini, Marina Talamonti
Published: 202510.1080/09546634.2025.2578249
Abstract
OBJECTIVES: Baricitinib has shown efficacy and a favorable safety profile in randomized trials for moderate-to-severe atopic dermatitis (AD), but real-world evidence is limited. We conducted a multicenter, retrospective and prospective study aimed at…
Preview only. Read the full abstract at the source